收藏切换
Real-world study of adverse event of risdiplam based on the Public Data Open Project of the US Food and Drug Administration
收藏切换
PDF
Bo LI, Ke ZHANG, Xuan SUN, Zheng-xiang LI
Chinese Journal of New Drugs | 2023, 32(14) : 1482 - 1488
Less
收藏切换
Chinese Journal of New Drugs | 2023, 32(14): 1482-1488
Real-world study of adverse event of risdiplam based on the Public Data Open Project of the US Food and Drug Administration
Full
Bo LI, Ke ZHANG, Xuan SUN, Zheng-xiang LI
Affiliations
  • Department of Pharmacy, Tianjin Medical University General Hospital, Tianjin 300052, China
Published: 2023-07-30
Outline
收藏切换
Objective:

To explore the adverse reactions of risdiplam based on Public Data Open Project of the US Food and Drug Administration (OpenFDA) in order to provide reference for clinical drug safety.

Methods:

The relevant data of risdiplam were searched and extracted from the OpenFDA database from August 7, 2020 to May 31, 2022. And the report odds ratio (ROR) and proportional report odds ratio (PRR) were applied for signal detection.

Results:

A total of 844 adverse event (ADE) reports with risdiplam as a primary suspicious drug were retrieved, and 68 adverse drug reactions (ADR) risk signals were detected, including positional vertigo, decreased oxygen saturation, tachycardia, and accelerated heart rate, which were not labeled in package insert. Top 5 ADE reports were product storage errors, gastrointestinal dysfunction, muscle weakness, diarrhea and weakness. Top 5 ADES in signal strength included diaper dermatitis, positional vertigo, respiratory tract infection virus, product temperature drift, and skin contact exposure.

Conclusion:

It is helpful to use real-world data for assessing the potential adverse reactions of risdiplam, suggesting clinicians to monitor specific adverse events and conduct further drug safety evaluations. The signal strength of positional vertigo is high and is not mentioned in the instruction manual, thus it is necessary for clinicians to pay close attention.

risdiplam  /  adverse event  /  US Food and Drug Administration Public Data Open Project  /  data mining
Bo LI, Ke ZHANG, Xuan SUN, Zheng-xiang LI. Real-world study of adverse event of risdiplam based on the Public Data Open Project of the US Food and Drug Administration[J]. Chinese Journal of New Drugs, 2023 , 32 (14) : 1482 -1488 .
Year 2023 volume 32 Issue 14
PDF
34
11
Cite this Article
BibTeX
Article Info
  • Online Date:2026-03-05
  • Published:2023-07-30
Article Data
Affiliations
History
  • Accepted:2022-09-05
Funding
Affiliations
    Department of Pharmacy, Tianjin Medical University General Hospital, Tianjin 300052, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT